Top Medical Searches

J&J Cancer Drug Gets Europe Approval

European drug regulators have approved Johnson & Johnson’s new prostate-cancer treatment Zytiga for men whose disease has progressed after chemotherapy. Read more…

Be Sociable, Share!
September 7th, 2011 Posted in Drug
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us